The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Case Report: A 50-Year-Old Man Suffers Dye-Induced Arthritis

Case Report: A 50-Year-Old Man Suffers Dye-Induced Arthritis

December 18, 2019 • By Hrudya Abraham, MD, Eric Warm, MD, FACP, & Avis Ware, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Hair dye being applied to a man’s beard.Hair dye products are commonly used by both men and women to enhance youth and beauty and to follow fashion trends. As reported in the medical literature, hair dyes and their ingredients are associated with allergic contact dermatitis. A possible association with joint inflammation has also been recognized. There is literature to support that para-phenylenediamine or p-phenylenediamine (PPD), a component of many hair dyes, is proinflammatory and also associated with an increased risk of developing systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This case illustrates the need to increase awareness about chemicals found in hair dyes and the possible links to inflammatory arthritis and other autoimmune diseases.

You Might Also Like
  • Case Report: RA Patient Suffers Methotrexate-Induced Cutaneous Lesions
  • Case Study: 66-Year-Old Man with Visual Loss, Headache, Hematuria, Chronic Sinusitis
  • Case Report: Metoprolol-Induced Arthralgia
Explore This Issue
December 2019

Case Presentation

A 50-year-old white man, with a past medical history remarkable for asthma, allergic rhinitis and treated latent tuberculosis, described low back, hand and Achilles tendon pain he’d been experiencing for four months. The pain restricted his recreational activities, including playing guitar and running, but he did get some relief when he took naproxen.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

He said he had not experienced psoriasis, skin rash, nail changes, diarrhea, uveitis, urethritis, joint swelling, fever, fatigue or weight loss. A review of systems was otherwise unremarkable.

His sister has a history of psoriatic arthritis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The physical exam revealed that he had swollen and tender second and third proximal interphalangeal joints and right third metatarsal joint on his right hand, as well as swelling and tenderness in the first interphalangeal and metacarpophalangeal joints on his left hand. He also had right elbow tenderness, with slightly reduced right elbow extension. The range of motion in the rest of his joints was normal. There was no evidence of a skin rash, dactylitis, enthesitis, nail pitting or sacroiliac joint pain.

Lab tests, including those for complete blood count, comprehensive metabolic panel, sedimentation rate, C-reactive pro­tein, anti-CCP antibodies, hepatitis B and C, and QuantiFERON-TB gold were unremarkable. However, a rheumatoid factor test was positive at 22 IU/mL (normal: <14 IU/mL).

The patient was hesitant to start on disease-modifying anti-rheumatic drugs (DMARDs) for inflammatory joint pain due to the potential side effects. Thus, the rheumatologist chose to follow him closely to assess disease progression.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Eight months after the initial onset of his symptoms, the patient’s joint pain completely resolved, and he was able to get back to his routine recreational activities. He noticed a correlation between the onset of joint pains and the use of hair dye on his beard. He decided to stop using the hair dye and noticed the joint pain had resolved. He is now able to run and play his guitar.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions Tagged With: case report, environmental factor, para-phenylenediamine (PPD)Issue: December 2019

You Might Also Like:
  • Case Report: RA Patient Suffers Methotrexate-Induced Cutaneous Lesions
  • Case Study: 66-Year-Old Man with Visual Loss, Headache, Hematuria, Chronic Sinusitis
  • Case Report: Metoprolol-Induced Arthralgia
  • Rheumatology Case Report: Monoarticular Arthritis in Pregnancy

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)